Parallel Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5K Buy
563
+271
+93% +$5.97K ﹤0.01% 2929
2026
Q2
$5.59K Sell
292
-1,323
-82% -$23K ﹤0.01% 3169
2026
Q1
$25.6K Buy
1,615
+542
+51% +$9.47K ﹤0.01% 2363
2025
Q4
$19.1K Buy
+1,073
New +$18.8K ﹤0.01% 2317
2025
Q2
– Sell
-84
Closed -$2.07K – 3637
2025
Q1
$2.07K Sell
84
-4
-5% -$99 ﹤0.01% 2968
2024
Q4
$2.04K Hold
88
– – ﹤0.01% 2966
2024
Q3
$2.39K Hold
88
– – ﹤0.01% 2846
2024
Q2
$2.53K Hold
88
– – ﹤0.01% 2740
2024
Q1
$2.57K Sell
88
-28
-24% -$783 ﹤0.01% 2747
2023
Q4
$3.77K Buy
+116
New +$3.36K ﹤0.01% 2604
2021
Q4
– Sell
-65
Closed -$4K – 3189
2021
Q3
$4K Buy
+65
New +$4.22K ﹤0.01% 2461

Other funds holding KIDS

Parallel Advisors's KIDS Position: Q3 2026 in Review

Parallel Advisors increased its OrthoPediatrics (KIDS) stake by 93% in Q3 2026, buying an estimated $5.97K and bringing the position to 563 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Parallel Advisors first reported a position in KIDS in Q3 2021 and has held it in 11 quarters since. The position peaked at $25.6K in Q1 2026. 31 funds tracked by Wall St. Rank hold KIDS as of Q3 2026.

  • Parallel Advisors held 563 shares of OrthoPediatrics worth $12.5K as of Q3 2026.
  • Parallel Advisors bought 271 OrthoPediatrics shares in Q3 2026, an estimated $5.97K.
  • OrthoPediatrics made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #2929 holding.
  • Parallel Advisors first reported a position in OrthoPediatrics in Q3 2021 and has held it in 11 quarters since.
  • Parallel Advisors's OrthoPediatrics position peaked at $25.6K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.